Efficacy and acceptability of pharmacological, psychosocial, and brain stimulation interventions in children and adolescents with mental disorders: an umbrella review

CU Correll, S Cortese, G Croatto, F Monaco… - World …, 2021 - Wiley Online Library
Top‐tier evidence on the safety/tolerability of 80 medications in children/adolescents with
mental disorders has recently been reviewed in this journal. To guide clinical practice, such …

Mental health problems in children with intellectual disability

V Totsika, A Liew, M Absoud, C Adnams… - The Lancet Child & …, 2022 - thelancet.com
Intellectual disability ranks in the top ten causes of disease burden globally and is the top
cause in children younger than 5 years. 2–3% of children have an intellectual disability, and …

Intellectual disability and language disorder

N Marrus, L Hall - Child and Adolescent Psychiatric …, 2017 - childpsych.theclinics.com
Intellectual Disability and Language Disorder - Child and Adolescent Psychiatric Clinics Skip
to Main Content Advertisement Child and Adolescent Psychiatric Clinics of North America Log …

Positive behavioural support in the UK: a state of the nation report

NJ Gore, SJ Sapiets, LD Denne… - … Journal of Positive …, 2022 - ingentaconnect.com
The 2013 International Journal of Positive Behavioural Support (IJPBS) special issue
acknowledged the evolving nature of positive behavioural support (PBS). This “state of the …

[HTML][HTML] Narrative review of intellectual disability: definitions, evaluation and principles of treatment

DR Patel, R Apple, S Kanungo, A Akkal - Pediatric Medicine, 2018 - pm.amegroups.org
Methods: We conducted a literature search (2005-2020) using online database PubMed,
specifically for studies related to the clinical aspects of intellectual disability as they apply to …

Non-pharmacological and pharmacological interventions for the reduction or prevention of topographies of behaviours that challenge in people with intellectual …

L Groves, C Jones, A Welham, A Hamilton… - The Lancet …, 2023 - thelancet.com
Background People with intellectual disability show a high prevalence of behaviours that
challenge. Clinical guidelines recommend that such behaviour should first be treated with …

Aripiprazole in children and adolescents

N Coustals, ML Ménard, D Cohen - Journal of Child and Adolescent …, 2021 - liebertpub.com
Objective: To review the use of aripiprazole in children and adolescents. Methods: Medline
and Embase databases were systematically searched using the keywords aripiprazole and …

Withdrawing Antipsychotics for Challenging Behaviours in Adults with Intellectual Disabilities: Experiences and Views of Prescribers

G de Kuijper, J de Haan, S Deb, R Shankar - International journal of …, 2022 - mdpi.com
International current best practice recommends the discontinuation of antipsychotics for
challenging behaviours in people with intellectual disabilities (ID), due to lack of evidence of …

Safety and tolerability of antipsychotic agents in neurodevelopmental disorders: a systematic review

F Iasevoli, A Barone, EF Buonaguro… - Expert Opinion on …, 2020 - Taylor & Francis
ABSTRACT Introduction Neurodevelopmental disorders (NDDs) are a group of complex and
heterogeneous disorders, caused by the disruption of normal brain development …

Gene× environment interaction in developmental disorders: where do we stand and what's next?

G Esposito, A Azhari, JL Borelli - Frontiers in psychology, 2018 - frontiersin.org
Although the field of psychiatry has witnessed the proliferation of studies on Gene×
Environment (G× E) interactions, still limited is the knowledge we possess of G× E …